(8-10).
The INK4a/ARF locus encodes two different proteins
The two cell cycle inhibitors, p16 INK4a and p19 ARF , seem to involved in cell cycle control. Both molecules, p16 INK4a and be regulated through different mechanisms. p16 INK4a appears p19 ARF , inhibit cell cycle progression and have been shown to be regulated by the retinoblastoma protein (pRb), responds to act as tumor suppressors in a variety of models. Their to Ras oncogenic stimulus and is induced in replicative expression is controlled by separate promoters responding senescence (11-13). This tumor suppressor gene is frequently to different stimuli and they therefore show independent inactivated by homozygous deletions (in many cases also transcriptional regulation. We have cloned and characterinvolving p15 INK4b , which is located very close on the chromoized a 2.5 kb region upstream of the murine p19 ARF gene some), point mutations in the coding sequence or hypermethylto determine the role of DNA methylation in suppressing ation of the CpG island in the promoter region in various p19 ARF transcription in a wide panel of murine primary T types of malignancies (14-17). The expression of p19 ARF , in cell lymphomas. This region contains a DNA fragment contrast, has been found to be regulated by several molecules with the characteristics of a CpG island similar to those in addition to Ras, including Myc, E2F-1 and E1A, and is described for the murine p16 INK4a and p15 INK4b genes.
down-regulated by p53, although no binding sequences for Expression of p19 ARF is decreased in a significant number p53 have been found in its promoter (18) (19) (20) (21) (22) . Recently, the (20%) of the murine lymphomas analyzed. Overexpression transcription factor DMP1 has been shown to play an important of the p19 ARF transcript is also frequent, suggesting alterarole in p19 ARF induction in response to anti-proliferative signals tions in molecules of the retinoblastoma or p53 pathways (23). In humans, the p19 ARF (also named p14 ARF ) promoter that are involved in p19 ARF regulation. Although hypermehas been cloned and sequenced (19, 21) and it has been shown thylation of the INK4a and INK4b promoters is frequently to be hypermethylated in some cell lines, correlating with involved in murine lymphomas, the p19 ARF CpG island is suppression of promoter activity (21) .
infrequently methylated in the murine primary lymphomas
In order to analyze the methylation status of the p19 ARF studied in this work. Since loss of p19 ARF expression cannot promoter in primary tumors, we have cloned and sequenced be explained as the result of homozygous deletions or the murine p19 ARF promoter and studied hypermethylation of hypermethylation of the ARF gene, other regulatory mechthis region as a model for the inactivation of p19 ARF expression anisms seem to be altered in these malignancies.
in a set of 64 murine primary T cell lymphomas. (Figure 1) .
Abbreviations: Rb, retinoblastoma; pRb, retinoblastoma protein. The presence of a CpG island was analyzed using (CCCGGATGC) has been functionally characterized previously (23). In general, the organization and the number of the parameters described previously (24). Computer analysis detected a 1 kb region with the characteristics of a CpG island transcription factor binding sequences are similar to those of the human ARF promoter (21) . immediately upstream of exon 1 of p19 ARF (Figure 1) . The GϩC content of this region is 0.69, whereas the CpG content Since p19 ARF is frequently inactivated in a variety of tumors, we have carried out RT-PCR expression analysis of the p19 ARF and the CpG/GpC ratio are 12.6% and 0.98, respectively. Thus, the genomic sequences upstream of p19 ARF show the gene with RNAs extracted from 110 T cell lymphomas induced with γ-irradiation in BCF1 (C57BL/6J malesϫBALBc/J characteristics of a typical CpG island following the previously described criteria (26, 27) . The density of CpG dinucleotides females), CBF1 (BALBc/J malesϫC57BL/6J females) and BRF1 (C57BL76J femalesϫRF/J males) hybrids. Thymic in this DNA fragment is even higher than that described for the murine p16 INK4a and p15 INK4b genes (24), which flank the lymphomas were induced using whole body γ-irradiation as described (29, 30) . Normal and tumoral tissues were collected p19 ARF exon 1β.
The analysis of potential transcriptional binding sites was for histology and DNA and RNA analyses. Non-irradiated F1 hybrids were used as controls to compare the level of basal carried out using several public computer resources, such as TFSEARCH (http://www.genome.ed.jp/SIT/TFSEARCH.html) expression in the thymus. RT-PCR analysis of p19 ARF expression was carried out with 10 µg of total RNA reverse and MatsInspector (http://www.gsf.de/cgi-bin/matsearch.pl). Numerous potential transcription factor binding sites are loctranscribed using a random hexanucleotide mix (Roche Molecular Biochemicals) and 3 U of AMV reverse transcriptase ated upstream of the transcription initiation site and within the CpG island, including binding sites for the transcription factors (Finnzymes Oy) in the appropriate buffer. One microliter of this reaction was then used for gene-specific PCR amplification. Sp1, DMP1 and members of the E2F family (Figure 1) . The importance of the E2F and DMP1 binding sites in human
In each sample, analysis of the CDK4 gene was used as a control for the validity of the cDNA mixture and DNA genomic p19 ARF regulation has been previously studied (21, 23 ) and Sp1 binding domains are frequently found in the CpG islands of contamination (data not shown). Primers used for CDK4 amplification were CDK4-F (5Ј-TGG CTG CCA CTC GAT many genes (28) and, in some cases, are involved in protection against de novo methylation of CpG islands (29) . In the murine ATG AAC-3Ј) and CDK4-R (5Ј-CCT CAG GTC CTG GTC TAT ATG-3Ј). Cycling conditions were: 94°C for 5 min; 35 p19 ARF promoter sequence described in this study, potential Sp1 sites are at positions -10 (GGGGCTGGGG), -50 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 1 min; a final step of 7 min at 72°C. Under these conditions, a 302 bp band is amplified from the processed RNA and a 400 bp genomic fragment (containing a small intron) is amplified when the samples are contaminated with genomic DNA. RNA preparations with genomic DNA contamination were removed from the study. p19 ARF cDNA amplification was carried out using primers p16-1βF (5Ј-AGT ACA GCA GCG GGA GCA TG-3Ј) (31) and p16-1R (5Ј-TAG CTC TGC TCT TGG GAT TG-3Ј) (24) and cycling conditions were: 94°C for 5 min; 35 cycles of 94°C for 30 s, 60°C for 45 s and 72°C for 2 min; a final step of 7 min at 72°C. Detection was carried out by 1.5% agarose gel electrophoresis and transfer to nylon membranes. Filters were hybridized with a PCR probe of exon 1β of p19 ARF (primers described in ref. 31), labeled and detected using the digoxigenin system (Roche Molecular Biochemicals). Scanning and densitometry of the autoradiographs (1D Analysis and Hand Scanner Settings; Biomed Instruments, Zeineh Programs) were performed to quantify the PCR products. β-Actin amplification (24) was used as a control of RNA integrity and concentration. Results revealed that 15.6% (10/64) of the tumors showed absence of the p19 ARF cDNA band while β-actin analysis revealed normal expression (Figure 2 ). Nine percent of the tumors (6/64) presented decreased p19 ARF mRNA expression as compared with controls and~47% of the tumors (30/64) showed augmented mRNA expression. In 28% (18/64) of the cases, p19 ARF expression levels were indistinguishable from those obtained in control tissues. In order to study whether the absence of p19 ARF expression was due to de novo methylation of the promoter sequences, we carried out methylation analyses of the CpG island. Different methylation-sensitive restriction endonucleases within the most CpG-rich region of the promoter were selected. Thus, we carried out double digestions of tumor DNA with XhoI, SmaI or EagI together with the methylation-insensitive restriction enzyme EcoRI. Twenty micrograms of genomic developed after 4-5 days exposure. Southern blots of 34 genomic DNAs from T cell primary lymphomas doubly digested with EcoRI and XhoI were hybridized with a p19 ARF hypermethylation in the p15 INK4b and p16 INK4a CpG islands using a similar approach (24), we cannot rule out that some exon 1β probe. No methylation at the XhoI site was detected in any of the tumors studied (Figure 2 ). In addition, 15 tumors, partial, non-dense methylation can occur in other positions of the p19 ARF promoter not analyzed in this study. including the ones with decreased p19 ARF expression, were tested with double digestion with EcoRI and EagI, revealing DNA methylation of regulatory regions has been accepted as a common mechanism for the inactivation of tumor suppressor only two tumors (13%) with partial methylation at the CpG island of the p19 ARF promoter (Figure 2) . No methylation was genes in cancer (32) . CpG islands in the promoter region of housekeeping genes are usually non-methylated in normal observed in EcoRI and SmaI digestions (data not shown). Our results clearly show that the number of methylated samples is tissues but, in the case of some tumor suppressor genes, can suffer de novo methylation leading to transcriptional low and that the ratio of methylated to non-methylated DNA is low in the positive samples. Less than 50% of the DNA is inactivation (15, 16, 24, 32) . This mechanism has been shown to be responsible for the loss of p15 INK4b and p16 INK4a expresmethylated at the EagI site, as detected by the presence of the 3.2 kb band (Figure 2 ). More significantly, none of the two sion in murine lymphomas induced by different treatments (24, 33, 34) . This is specially relevant in the case of p15 INK4b , methylated samples showed loss of p19 ARF expression in the RT-PCR analysis, indicating that this partial methylation is a tumor suppressor gene specifically altered in hematopoietic malignancies, where hypermethylation in its regulatory not physiologically relevant. These results indicate that the p19 ARF CpG island is not frequently and densely methylated sequences occurs independent of p16 INK4a alterations. Although the human p19 ARF promoter has been found to be methylated in these tumors. However, although we have detected strong in some cell lines (21), we have found only rare cases of and p16 INK4a inactivation, would produce increased levels of active cellular E2F proteins, giving rise to p19 ARF overexprespartial methylation at the EagI site in a proximal location to exon 1β in primary tumors. This methylation, however, does sion. Therefore, the increased levels of p19 ARF in some tumors is likely to be due to additional alterations in other members not extend to a second EagI site in the 5Ј-region of the CpG island (Figure 1) . Similarly, methylation of the human p19 ARF of the p53 and/or Rb pathways. In summary, we have described here the genomic sequence CpG island does not extend significantly beyond -450 relative to the transcription start site (21) . Although DNA hypermethylupstream of the mouse p19 ARF gene, showing the presence of a CpG island susceptible to de novo methylation and ation in the promoter region of tumor suppressor genes usually correlates with decreased expression, that is not the case for corresponding transcriptional down-regulation. A recent report on human tumors has shown that the human p19 ARF gene is our two positive samples, where the level of methylation present is insufficient to suppress transcription, as these samples infrequently methylated in human B and T cell lymphomas (40). In our hands, p19 ARF expression is frequently lost express significant amounts of p19 ARF RNA.
The specificity of DNA methylation in the different CpG or decreased in γ-irradiation-induced mouse primary thymic lymphomas (up to 20% of the tumors), although this alteration islands of the INK4b-INK4a/ARF loci is an intriguing finding. Although these sequences are located in close proximity on cannot be explained as a result of CpG hypermethylation at the promoter sequences. the chromosome (Figure 1) there is an interesting specificity in their methylation patterns in mouse lymphomas. These differences can be explained as a result of the specific role ofE2F family (21) and any increase in pRb phosphorylation by 
